1. Home
  2. PBPB vs CAPR Comparison

PBPB vs CAPR Comparison

Compare PBPB & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBPB
  • CAPR
  • Stock Information
  • Founded
  • PBPB 1977
  • CAPR 2005
  • Country
  • PBPB United States
  • CAPR United States
  • Employees
  • PBPB N/A
  • CAPR N/A
  • Industry
  • PBPB Restaurants
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PBPB Consumer Discretionary
  • CAPR Health Care
  • Exchange
  • PBPB Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • PBPB 305.0M
  • CAPR 324.6M
  • IPO Year
  • PBPB 2013
  • CAPR N/A
  • Fundamental
  • Price
  • PBPB $12.94
  • CAPR $6.28
  • Analyst Decision
  • PBPB Strong Buy
  • CAPR Strong Buy
  • Analyst Count
  • PBPB 2
  • CAPR 8
  • Target Price
  • PBPB $17.50
  • CAPR $24.75
  • AVG Volume (30 Days)
  • PBPB 257.0K
  • CAPR 1.4M
  • Earning Date
  • PBPB 08-06-2025
  • CAPR 08-11-2025
  • Dividend Yield
  • PBPB N/A
  • CAPR N/A
  • EPS Growth
  • PBPB N/A
  • CAPR N/A
  • EPS
  • PBPB 0.35
  • CAPR N/A
  • Revenue
  • PBPB $469,138,000.00
  • CAPR $13,392,150.00
  • Revenue This Year
  • PBPB $5.28
  • CAPR N/A
  • Revenue Next Year
  • PBPB $4.30
  • CAPR $6,061.53
  • P/E Ratio
  • PBPB $37.36
  • CAPR N/A
  • Revenue Growth
  • PBPB N/A
  • CAPR N/A
  • 52 Week Low
  • PBPB $7.27
  • CAPR $3.98
  • 52 Week High
  • PBPB $13.67
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • PBPB 57.95
  • CAPR 36.33
  • Support Level
  • PBPB $12.78
  • CAPR $6.17
  • Resistance Level
  • PBPB $13.18
  • CAPR $7.30
  • Average True Range (ATR)
  • PBPB 0.38
  • CAPR 0.43
  • MACD
  • PBPB 0.05
  • CAPR -0.11
  • Stochastic Oscillator
  • PBPB 81.10
  • CAPR 4.53

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: